The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30. According to MarkNtel Advisors Study.
Global Dry Eye Syndrome Market Driver:
Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.
Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including(TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html
Global Dry Eye Syndrome Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2023
-Historical Period: 2019 to 2022
-Forecast Period: 2024 to 2030
- By Product
- Artificial Tears- Market Size & Forecast 2019-2030, USD Million
- Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
- Cyclosporine– Market Size & Forecast 2019-2030, USD Million
- Corticosteroid– Market Size & Forecast 2019-2030, USD Million
- Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
- Dissolvable– Market Size & Forecast 2019-2030, USD Million
- Removable– Market Size & Forecast 2019-2030, USD Million
- Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million
- By Disease Type
- Aqueous Dry Eye – Market Size & Forecast 2019-2030, USD Million
- Evaporative Dry Eye – Market Size & Forecast 2019-2030, USD Million
- By Distribution Channel
- Offline- Market Size & Forecast 2019-2030, USD Million
- Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
- Hospital Pharmacies – Market Size & Forecast 2019-2030, USD Million
- Online- Market Size & Forecast 2019-2030, USD Million
- Offline- Market Size & Forecast 2019-2030, USD Million
- By Competition
- Competition Characteristics
- Market Share Analysis
- By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Mitotech Pharma, ReGen Tree, Santen Pharmaceutical, HanAll Biopharma, Sun Pharma, Novaliq, Sylentis, Alcon, Horus pharma, Johnson& Johnson, Aldreya Therapeutics, Visufarma, Allergen, Prestige Consumer Health, Others are looking forward to strengthening their market positions.
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/dry-eye-disease-drugs-market.html
Data-Driven Insights Backed by Proven Research
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
